Mengis Capital Management, Inc. Abbott Laboratories Transaction History

Mengis Capital Management, Inc.

$497 Million
Q3 2024

A detailed history of Mengis Capital Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Mengis Capital Management, Inc. holds 4,515 shares of ABT stock, worth $518,141. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,515

Previous 4,515 -0.0%

Holding current value

$518,141

Previous $469,000 9.59%

% of portfolio

0.1%

Previous 0.1%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $47,746 - $53,296	-474 Reduced 9.5%	4,515 $469,000
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $52,022 - $57,456	475 Added 10.52%	4,989 $567,000
Q3 2023 Nov 09, 2023	SELL	$95.53 - $114.62 $4,776 - $5,731	-50 Reduced 1.1%	4,514 $437,000
Q2 2023 Aug 08, 2023	BUY	$100.78 - $112.29 $100 - $112	1 Added 0.02%	4,564 $497,000
Q3 2022 Nov 04, 2022	SELL	$96.76 - $112.03 $14,514 - $16,804	-150 Reduced 3.18%	4,563 $441,000
Q2 2022 Jul 19, 2022	BUY	$102.07 - $123.37 $6,226 - $7,525	61 Added 1.31%	4,713 $512,000
Q4 2021 Feb 04, 2022	SELL	$115.53 - $141.46 $3,465 - $4,243	-30 Reduced 0.64%	4,652 $654,000
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $15,868 - $18,679	-150 Reduced 3.1%	4,682 $542,000
Q4 2020 Feb 03, 2021	SELL	$105.0 - $114.42 $49,875 - $54,349	-475 Reduced 8.95%	4,832 $529,000
Q3 2020 Oct 29, 2020	SELL	$91.64 - $111.29 $6,598 - $8,012	-72 Reduced 1.34%	5,307 $577,000
Q2 2020 Jul 22, 2020	SELL	$76.57 - $98.0 $59,341 - $75,950	-775 Reduced 12.59%	5,379 $491,000
Q1 2020 May 06, 2020	SELL	$62.82 - $91.86 $11,307 - $16,534	-180 Reduced 2.84%	6,154 $485,000
Q3 2019 Nov 05, 2019	BUY	$81.84 - $88.74 $14,322 - $15,529	175 Added 2.84%	6,334 $529,000
Q1 2019 May 06, 2019	BUY	$66.22 - $80.06 $8,608 - $10,407	130 Added 2.16%	6,159 $492,000
Q4 2018 Feb 06, 2019	SELL	$65.56 - $74.27 $26,224 - $29,708	-400 Reduced 6.22%	6,029 $436,000
Q3 2018 Nov 05, 2018	SELL	$60.81 - $73.36 $6,081 - $7,336	-100 Reduced 1.53%	6,429 $471,000
Q1 2018 Apr 27, 2018	SELL	$56.27 - $63.62 $5,627 - $6,362	-100 Reduced 1.51%	6,529 $391,000
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $318,589 - $355,579	6,629	6,629 $353,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mengis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mengis Capital Management, Inc. with notifications on news.

Account

Mengis Capital Management, Inc. Abbott Laboratories Transaction History